» Authors » Fotini Fligou

Fotini Fligou

Explore the profile of Fotini Fligou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 563
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Papadimitriou-Olivgeris M, Panteli E, Koutsileou K, Boulovana M, Zotou A, Marangos M, et al.
Braz J Anesthesiol . 2021 Mar; 71(1):23-30. PMID: 33712248
Background And Objectives: Worldwide, trauma is one of the leading causes of morbidity and mortality. The aim of the present study is to identify the predictors of mortality of trauma...
12.
Kiekkas P, Tsekoura V, Fligou F, Tzenalis A, Michalopoulos E, Voyagis G
J Perianesth Nurs . 2021 Feb; 36(3):232-237. PMID: 33618995
Purpose: This study aimed to investigate the prevalence, activities, and reasons for missed nursing care in the postanesthesia care unit (PACU) and the effect of intensive care unit (ICU) overflow...
13.
Aretha D, Leukaditou K, Fligou F, Akinosoglou K, Spyridonidis A, Nikolopoulou A, et al.
J Clin Med Res . 2021 Feb; 13(1):64-72. PMID: 33613801
Background: Immunoglobulins (Igs) and cells of the innate and adaptive immune systems play a critical role in a host's response to sepsis. The aim of this study was to investigate...
14.
Papadimitriou-Olivgeris M, Bartzavali C, Georgakopoulou A, Kolonitsiou F, Papamichail C, Spiliopoulou I, et al.
Antibiotics (Basel) . 2021 Jan; 10(1). PMID: 33467394
Background: The increased frequency of bacteraemias caused by pandrug-resistant (PDR-Kp) has significant implications. The aim of the present study was to identify predictors associated with mortality of PDR-Kp bacteraemias. Methods:...
15.
Papadimitriou-Olivgeris M, Bartzavali C, Georgakopoulou A, Kolonitsiou F, Mplani V, Spiliopoulou I, et al.
Clin Microbiol Infect . 2021 Jan; 27(6):915.e1-915.e3. PMID: 33444757
Objectives: Our aim was to validate the INCREMENT-CPE score (ICS) in patients hospitalized in the intensive care unit (ICU) with bacteraemia due to carbapenemase-producing Klebsiella pneumoniae (CP-Kp). Methods: The study...
16.
Papadimitriou-Olivgeris M, Bartzavali C, Nikolopoulou A, Kolonitsiou F, Mplani V, Spiliopoulou I, et al.
Antibiotics (Basel) . 2020 Nov; 9(11). PMID: 33228012
Background: Tigecycline is a therapeutic option for carbapenemase-producing (CP-Kp). Our aim was to evaluate the impact of the tigecycline's minimum inhibitory concentration (MIC) in the outcome of patients with CP-Kp...
17.
Aretha D, Kiekkas P, Sioulas N, Fligou F
SAGE Open Med . 2020 Oct; 8:2050312120962338. PMID: 33062276
Background: Once a patent expires, generic analogue drugs are alternatives to brand name drugs. Because bioequivalence/biodistribution problems have been reported for many generic analogue drugs, we prospectively evaluated 31 patients...
18.
Tsolakis I, Kakkos S, Papageorgopoulou C, Papadoulas S, Lampropoulos G, Fligou F, et al.
Ann Vasc Surg . 2020 Sep; 71:370-380. PMID: 32890639
Background: The aim of this study is to identify preoperative and intraoperative factors associated with in-hospital mortality of intact abdominal aortoiliac aneurysm repair. Methods: In this observational study, prospectively collected...
19.
Karamouzos V, Fligou F, Gogos C, Velissaris D
Monaldi Arch Chest Dis . 2020 Jun; 90(2). PMID: 32512988
The novel corona virus (SARS-CoV-2) continuous to spread around the globe causing high mortality, tremendous stress on healthcare systems and an unprecedented disruption of everyday life with unpredictable socioeconomic ramifications....
20.
Papadimitriou-Olivgeris M, Kolonitsiou F, Karamouzos V, Tsilipounidaki K, Nikolopoulou A, Fligou F, et al.
Eur J Clin Microbiol Infect Dis . 2020 Jan; 39(5):863-869. PMID: 31898796
To identify the molecular characteristics of Gram-positive cocci isolated from blood cultures and clinical outcome among critically ill patients. This retrospective study was conducted in the general intensive care unit...